Altria on! PLUS Reaches 120,000 Stores: What's Next for Growth?

Zacks
Open on Zacks
Altria on! PLUS Reaches 120,000 Stores: What's Next for Growth?

Altria Group, Inc.’s MO on! PLUS has moved into a broader phase of expansion after reaching about 120,000 stores nationwide in the second quarter of 2026. The retail footprint covers roughly 90% of nicotine-product volume, giving the brand substantial availability following its national rollout. The expansion is already contributing to on!’s performance, with retail share reaching 8.6% in the second quarter, up 0.8 share points sequentially and 0.3 share points year over year. 

Volume trends also show the early contribution from on! PLUS. Reported on! shipment volume was 49.9 million cans in the second quarter, down 4.2% year over year because of trade inventory movements. However, first-half shipment volume increased 5.1%, reflecting the early impact of the on! PLUS expansion. Early retail data also indicated incremental volume contributions and encouraging repeat-purchase rates. Brand-building investments supported awareness, with on! brand awareness rising to 57% from 53% among adult nicotine consumers aged 21-54 in the first half. 

The next expansion phase centers on product variety. Shipments of 12-milligram on! PLUS resumed in Florida, North Carolina and Texas in three flavors, with national expansion planned for the third quarter. Additional flavors across 6, 9 and 12-milligram strengths, beginning with Blueberry Mint and Mango Pineapple, are planned for the fourth quarter. These additions broaden the portfolio beyond the initial rollout and extend the brand’s presence across strengths and flavors.

MO’s on! PLUS Faces Expanding Competition in Nicotine Pouches

Philip Morris International Inc. PM is strengthening its U.S. nicotine pouch position through ZYN. In the second quarter of 2026, ZYN shipments rose 1.8% to 2.9 billion pouches, while offtake was flat to slightly higher year over year. Philip Morris also launched 9 and 11-milligram ZYN ULTRA moist variants. In the third quarter, Philip Morris plans 1.5 and 8-milligram dry variants and higher U.S. investment. 

Turning Point Brands, Inc. TPB is also building momentum in nicotine pouches through FRE and ALP. In the second quarter of 2026, Modern Oral net sales surged 128% to $68.4 million and represented 48% of total company net sales. Turning Point Brands is expanding retail distribution, with chain-store count expected to rise 70% year over year by 2026-end. To support its Modern Oral brands, Turning Point Brands is also investing in sales and marketing.

Altria’s Price Performance, Valuation & Estimates

Shares of Altria have gained 0.5% in the past month compared with the industry’s growth of 1%.

Zacks Investment Research
Image Source: Zacks Investment Research

From a valuation standpoint, MO trades at a forward price-to-earnings ratio of 11.87X, down from the industry’s average of 15.18X.

Zacks Investment Research
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for MO’s 2026 and 2027 earnings implies year-over-year growth of 4.6% and 3%, respectively.

Altria currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Beyond Nvidia: AI's Second Wave Is Here

The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.

See Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Altria Group, Inc. (MO): Free Stock Analysis Report
 
Philip Morris International Inc. (PM): Free Stock Analysis Report
 
Turning Point Brands, Inc. (TPB): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research